Skip to main content
Donate
Welcome to Angelman Syndrome Genetics 101

This section reviews basic genetics concepts. For a a deeper dive, check out Genetics 201.

Our bodies are made of tiny building blocks called cells, and inside almost every cell, most people have 46 chromosomes. Think of chromosomes as instruction books that tell our bodies how to grow and work.  The chromosomes are arranged in pairs, and we typically get 23 chromosomes from our mother (maternal) and 23 from our father (paternal), for a total of 46 chromosomes.  

The chromosomes are made up of DNA and contain our genes.  Each gene gives an instruction to make a protein. Proteins do essentially everything in our body—controlling growth, development, and everyday functioning.  

An image showing genetics information breaking down chromosome 15 into DNA, a gene, and protein.
The UBE3A Gene

One important gene is called UBE3A, which is found on chromosome 15. This gene gives instructions to make the UBE3A protein. UBE3A protein is needed for activities like walking and talking.  Because most people have two copies of chromosome 15, most people have two copies of the UBE3A gene.   

An image of a neurotypical chromosome 15
Imprinting: UBE3A in the brain

In most body tissues, both copies of the UBE3A gene (one from each parent) are turned on. However, in brain cells, specifically neurons, only the maternal copy of UBE3A is turned on. Due to a process called imprinting, the paternal copy is turned off or silenced in everyone's neurons.  “Neurotypical” people (with regard to AS) have the maternal UBE3A gene turned on, paternal UBE3A gene turned off.

Image showing neurotypical vs Angelman syndrome and UBE3A protein being made.
What causes Angelman syndrome?

Angelman syndrome is caused by not enough functional UBE3A protein in the brain.  

People living with Angelman syndrome have a genetic difference that affects the maternal UBE3A gene.  That difference results in not enough functional UBE3A protein in the brain.   

Most often, this is because the maternal UBE3A gene is missing (Deletion) but it can also happen because of an error inside the gene (Mutation), because a person has two copies of the paternal UBE3A gene (Uniparental disomy (UPD)) or because the maternal UBE3A gene was incorrectly turned off (Imprinting center defect (ICD)).   

These genetic differences all result in the maternal UBE3A gene being absent or nonfunctional and are referred to as genotypes in AS.  Learn more about each AS genotype.

Showing neurotypical and 5 AS genotypes based on chromosome 15 impacts.

The bottom line is that when the maternal UBE3A gene is absent or nonfunctional, there is no UBE3A protein made in the brain.  This is what causes Angelman syndrome.   

Why does the absence of UBE3A protein in the brain cause Angelman syndrome?  

UBE3A protein helps control how brain cells communicate with each other. It works by marking certain other proteins for removal, which is important for keeping our brain cells healthy and functioning properly. When UBE3A is absent, other proteins can build up, interfering with how brains cells communicate, which then affects learning and muscle control.   

In most cases, Angelman syndrome isn’t inherited. Instead, the genetic differences that cause AS occur as random events during the formation of sperm or egg cells or in early embryonic development.  In more rare instances, it is inherited from a parent who carries a UBE3A mutation or a chromosome difference.  For more information on inheritance by specific genotype, click here. 

For the best overview of AS genetics, watch the video below by Dr. Allyson Berent, our Chief Science Officer.

For Genetics 201, head over to this page.

Return to menu, click here.

FAST Angelman Syndrome News

Disclaimer

This website contains information for a broad audience and may include information on current and upcoming programs that are not yet approved or accessible The information provided is for general informational purposes only and is not intended as medical advice, diagnosis, or treatment. While FAST strives to provide accurate and up-to-date information, the content on this site may not always reflect the most current research or clinical guidelines. The inclusion of clinical trial information, treatments or specific healthcare providers does not imply endorsement, recommendation or guarantee of safety, efficacy, or availability. Reliance on any information provided by this website is solely at your own risk. FAST disclaims any liability for any errors or omissions in the information provided or for any decisions made based on this information. For personalized medical advice or specific health concerns including participation in any clinical trial, please consult a qualified healthcare professional.